Tongxin Li, Jing Xu, Runyuan Wang, Wei Wu, Yu Zhou, Dong Wang, Wang He, Yi Wu, Ping He, Yong Fu
Clinical Medicine Department, North Sichuan Medical College, Nanchong, Sichuan, China.
Cardiothoracic Surgery Department, Dianjiang People's Hospital of Chongqing, Chongqing, China.
Front Surg. 2022 Apr 29;9:881076. doi: 10.3389/fsurg.2022.881076. eCollection 2022.
To compare the application of the emerging 3D printing technology and 3D-CT in segmentectomy. And to explore the advantages of 3D printing technology in thoracoscopic segmentectomy.
We collected the clinical data of 118 patients undergoing thoracoscopic segmentectomy from January 2019 to April 2021 at the Thoracic Surgery Department, the Dianjiang People's Hospital of Chongqing and Southwest Hospital. Among them, 61 patients were in the 3D printing group and 57 patients were in the 3D-CT group respectively. The perioperative data of these two groups of patients were analyzed respectively.
There were no significant differences between the two groups in age, gender, tumor diameter, pathology, the preoperative complications of diabetes and heart disease. However, the patients with the complications of hypertension in the 3D printing group are significantly more than the 3D-CT group ( = 0.003). Compared with the 3D-CT group, patients in the 3D printing group had significantly shorter operation time (162.7 ± 47.0 vs. 190.3 ± 56.9 min, = 0.006), less intraoperative fluid input (1,158.5 ± 290.2 vs. 1,433.2 ± 653.3, = 0.013), and less total intraoperative fluid output, including intraoperative blood loss, urine excretion, and other fluid loss. In addition, there were no statistically significant differences in intraoperative blood loss, 24 h pleural fluid volume, 48 h pleural fluid volume, postoperative chest tube duration, postoperative hospital stay and complications between the two groups of patients ( > 0.05).
In thoracoscopic segmentectomy, the application of 3D printing technology shortens the operation time, reduces intraoperative fluid input and output, guides the operation more safely and effectively, and has better clinical application value.
比较新兴的3D打印技术和3D-CT在肺段切除术中的应用情况。并探讨3D打印技术在胸腔镜肺段切除术中的优势。
收集2019年1月至2021年4月在重庆市垫江县人民医院胸外科和西南医院接受胸腔镜肺段切除术的118例患者的临床资料。其中，3D打印组61例患者，3D-CT组57例患者。分别分析两组患者的围手术期数据。
两组患者在年龄、性别、肿瘤直径、病理、术前糖尿病和心脏病并发症方面无显著差异。然而，3D打印组高血压并发症患者明显多于3D-CT组（P = 0.003）。与3D-CT组相比，3D打印组患者手术时间明显缩短（162.7±47.0 vs. 190.3±56.9分钟，P = 0.006），术中液体输入量更少（1158.5±290.2 vs. 1433.2±653.3，P = 0.013），术中总液体输出量更少，包括术中失血、尿液排出和其他液体损失。此外，两组患者在术中失血、24小时胸腔积液量, 48小时胸腔积液量、术后胸管留置时间、术后住院时间和并发症方面无统计学显著差异（P>0.05）。
在胸腔镜肺段切除术中，3D打印技术的应用缩短了手术时间，减少了术中液体的输入和输出，更安全有效地指导手术，具有较好的临床应用价值。
